GTF3C4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.189000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.194400E-01
Normal-vs-Stage2
8.412000E-01
Normal-vs-Stage3
2.230200E-01
Normal-vs-Stage4
1.706160E-01
Stage1-vs-Stage2
6.805000E-01
Stage1-vs-Stage3
7.261800E-02
Stage1-vs-Stage4
1.576250E-01
Stage2-vs-Stage3
1.514820E-01
Stage2-vs-Stage4
2.972100E-02
Stage3-vs-Stage4
2.287900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.345800E-01
Normal-vs-AfricanAmerican
7.474000E-01
Normal-vs-Asian
9.740000E-01
Caucasian-vs-AfricanAmerican
7.437600E-01
Caucasian-vs-Asian
6.443800E-01
AfricanAmerican-vs-Asian
6.467600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.225800E-01
Normal-vs-Female
8.134400E-01
Male-vs-Female
9.603400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.343000E-01
Normal-vs-Age(41-60Yrs)
4.958400E-01
Normal-vs-Age(61-80Yrs)
9.886000E-01
Normal-vs-Age(81-100Yrs)
8.382200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.304800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.288600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.705200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.396500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.071220E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.030200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.732600E-01
Normal-vs-Daily Drinker
4.897800E-01
Normal-vs-Weekly Drinker
8.232000E-01
Normal-vs-Occasional Drinker
4.960400E-01
Normal-vs-Social Drinker
4.686600E-01
Non Drinker-vs-Daily Drinker
2.258400E-01
Non Drinker-vs-Weekly Drinker
7.374000E-01
Non Drinker-vs-Occasional Drinker
8.798000E-02
Non Drinker-vs-Social Drinker
9.733500E-02
Daily Drinker-vs-Weekly Drinker
4.599400E-01
Daily Drinker-vs-Occasional Drinker
2.076500E-02
Daily Drinker-vs-Social Drinker
2.201800E-02
Weekly Drinker-vs-Occasional Drinker
1.085450E-01
Weekly Drinker-vs-Social Drinker
9.974400E-02
Occasional Drinker-vs-Social Drinker
9.498800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.409160E-01
Normal-vs-Grade 2
6.004100E-02
Normal-vs-Grade 3
2.802200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.851400E-01
Grade 1-vs-Grade 3
1.068000E-01
Grade 1-vs-Grade 4
1.409160E-01
Grade 2-vs-Grade 3
2.703200E-01
Grade 2-vs-Grade 4
6.004100E-02
Grade 3-vs-Grade 4
2.802200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.409200E-01
Normal-vs-NonDiabetic
8.926600E-01
Diabetic-vs-NonDiabetic
5.151400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.595200E-01
Normal-vs-NoPancreatitis
8.528000E-01
Pancreatitis-vs-NoPancreatitis
1.351830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.119800E-01
Normal-vs-N1
8.106000E-01
N0-vs-N1
9.271400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.433600E-01
Normal-vs-TP53-NonMutant
7.085400E-01
TP53-Mutant-vs-TP53-NonMutant
3.334600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
